Longevity & AgingResearch PaperPaywall

Hidden Survival Switch: cGAS-STING Pathway Drives Mitochondrial Cleanup

A newly discovered STING-OPTN signaling axis controls mitophagy, protecting cells from death by clearing damaged mitochondria.

Saturday, September 5, 2026 2 views
Published in Cell Rep
A glowing damaged mitochondrion being enveloped by an autophagosome membrane inside a human cell, molecular signals illuminated in blue.

Summary

Researchers have uncovered a surprising non-immune role for the cGAS-STING pathway: acting as a master regulator of mitophagy, the cellular process that clears damaged mitochondria. The study shows that STING recruits to mitochondria and activates TBK1, which then phosphorylates a receptor protein called optineurin (OPTN) to tag damaged mitochondria for autophagosomal destruction. This process depends on VCP/p97, a protein that strips away outer mitochondrial membrane proteins to allow STING docking. When this STING-OPTN axis is disrupted, mitophagy fails and cells switch to apoptosis — programmed death. The findings reframe cGAS-STING as a pro-survival pathway critical to mitochondrial quality control, with broad implications for aging, neurodegeneration, and inflammatory disease.

Detailed Summary

Mitochondrial quality control is a cornerstone of cellular longevity, and failures in this process are linked to aging, neurodegeneration, and chronic disease. At the center of this new study is an unexpected protagonist: the cGAS-STING innate immune pathway, best known for detecting foreign DNA and triggering interferon responses. This research reveals that STING has a second, non-canonical job — coordinating the selective removal of damaged mitochondria through mitophagy.

The team, led by researchers at Sun Yat-sen University and the University of Macau, found that activation of the kinase TBK1 during mitophagy is entirely dependent on the cGAS-STING pathway. Crucially, STING must first physically relocate to damaged mitochondria — a process gated by VCP/p97, a molecular machine that degrades outer mitochondrial membrane proteins to clear the landing zone for STING recruitment.

Once STING is anchored at the mitochondria, it activates TBK1, which phosphorylates optineurin (OPTN), a well-characterized autophagy receptor. Phosphorylated OPTN then efficiently targets the damaged mitochondria for engulfment by autophagosomes and subsequent lysosomal destruction — completing the mitophagy cycle.

The functional stakes are high: when the researchers disrupted the STING-OPTN axis, mitophagy stalled and cells pivoted toward apoptosis. This suggests the pathway acts as a cell-fate switch, determining whether a stressed cell survives through cleanup or commits to death.

These findings have broad implications for aging biology, where declining mitophagy is a hallmark of cellular deterioration. They also intersect with neurodegeneration research, as OPTN mutations are linked to ALS and glaucoma. A key caveat is that this study likely relied on cell-based models; in vivo and human validation will be essential before therapeutic targeting of this axis is feasible.

Key Findings

  • cGAS-STING pathway acts as an upstream positive regulator of mitophagy, independent of its immune signaling role.
  • TBK1 activation during mitophagy is strictly dependent on STING, which must physically recruit to damaged mitochondria.
  • VCP/p97 degrades outer mitochondrial membrane proteins to enable STING mitochondrial recruitment.
  • TBK1 phosphorylates optineurin (OPTN), driving efficient autophagosome-lysosome clearance of damaged mitochondria.
  • Disrupting the STING-OPTN axis switches the cellular response from protective mitophagy to apoptotic cell death.

Methodology

The study used molecular and cell biology approaches to dissect the STING-TBK1-OPTN signaling cascade during mitophagy. Genetic disruption and reconstitution experiments were used to establish pathway dependencies. The work appears to be primarily cell-based; the specific model systems (e.g., cell lines, primary cells) are not detailed in the abstract.

Study Limitations

The study is based on abstract-level information only, and specific experimental models (animal vs. cell line) are unclear. In vivo validation and human tissue studies are not described, limiting translational confidence. The dual immune and mitophagy roles of cGAS-STING may complicate therapeutic targeting without unintended inflammatory consequences.

Enjoyed this summary?

Get the latest longevity research delivered to your inbox every week.

Enter your email to subscribe: